Tag Archives: EMA

Mexico at the vanguard with new combination drug

Posted on November 29, 2013 by Maria I. Guaia

In the past days, COFEPRIS granted approval for the combination drug containing fluticasone furoate and vilanterol, indicated for treatment of chronic obstructive pulmonary disease (COPD) and asthma. Although the product had already been approved in the US by the FDA in … Continue reading →

Posted in Mexico | Tagged , , , , , , , , , , , , , , | 1 Comment

Brazil: ANVISA bans Lorcaserin (Belviq)

Posted on November 6, 2013 by Maria I. Guaia

Today ANVISA, the Brazilian health authority with competence on the control of pharmaceutical products and APIs, banned the manufacturing, import, commercialization, manipulation and use of the API Lorcaserin. Lorcaserin is the drug substance of Belviq, an innovative weight-loss product that … Continue reading →

Posted in Brazil | Tagged , , , , , , , , , , , , | 3 Comments